首页> 外国专利> TAIL VARIANT OF REDOX-ACTIVE THERAPEUTIC FOR TREATMENT OF MITOCHONDRIAL DISEASE AND OTHER CONDITION AND MODULATION OF ENERGY BIOMARKER

TAIL VARIANT OF REDOX-ACTIVE THERAPEUTIC FOR TREATMENT OF MITOCHONDRIAL DISEASE AND OTHER CONDITION AND MODULATION OF ENERGY BIOMARKER

机译:氧化还原酶疗法治疗线粒体疾病及其他情况的能量变化及能量生物标志物的调节

摘要

PROBLEM TO BE SOLVED: To provide compositions and methods useful for treatment or suppression of diseases due to mitochondrial disorders, such as Friedreich's ataxia, Leber's Hereditary Optic Neuropathy, Kearns-Sayre Syndrome, and mitochondrial myopathy, encephalopathy, lactacidosis, stroke (MELAS), and for modulating energy biomarkers in a subject.SOLUTION: The present invention provides compounds useful in treating or suppressing mitochondrial disorders, and methods of using such compounds for modulating of energy biomarkers. The redox active therapies for treatment or suppression of mitochondrial diseases and associated aspects of the invention are described in more detail herein.
机译:要解决的问题:提供可用于治疗或抑制线粒体疾病(例如弗里德里希共济失调,莱伯遗传性视神经病变,Kearns-Sayre综合征和线粒体肌病,脑病,乳酸中毒,中风(MELAS))的疾病的组合物和方法,解决方案:本发明提供可用于治疗或抑制线粒体疾病的化合物,以及使用此类化合物调节能量生物标志物的方法。本文更详细地描述了用于治疗或抑制线粒体疾病的氧化还原活性疗法和本发明的相关方面。

著录项

  • 公开/公告号JP2013155194A

    专利类型

  • 公开/公告日2013-08-15

    原文格式PDF

  • 申请/专利权人 EDISON PHARMACEUTICALS INC;

    申请/专利号JP20130098528

  • 发明设计人 MILLER GUY M;HECHT SIDNEY M;

    申请日2013-05-08

  • 分类号C07C39/08;A61K31/05;A61K31/122;A61P3/10;A61P13/02;A61P9;A61P21;A61P21/02;A61P25;A61P27/02;A61P35;A61P3/12;A61P25/16;A61P25/28;A61P25/08;A61P25/02;A61P27/12;A61P27/16;C07C50/04;

  • 国家 JP

  • 入库时间 2022-08-21 17:02:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号